Sign up Australia
Proactive Investors - Run By Investors For Investors

Centaurus Metals and Queensland Bauxite in hunt for top ASX % Gainer status

Queensland Bauxite gained investor interest with medical cannabis exposure
Centaurus Metals and Queensland Bauxite in hunt for top ASX % Gainer status
The leading ASX % Gainers intra-day

Centaurus Metals Ltd's (ASX:CTM) shares have gained 33% to A$0.004 following a significantly oversubscribed rights issue which raised A$2.5mln.

The funds will be allocated to the highly prospective Serra Misteriosa Gold Project and to commence a maiden exploration program at the recently secured Salobo West Copper-Gold Project. Both projects are located in Brazil.

Queensland Bauxite Ltd (ASX:QBL) has rallied 18% to A$0.013, after its subsidiary Medical Cannabis Limited (MCL) received a successful update regarding its winter cannabis crops.

Company Name Code Last Change Volume
Ziptel Ltd ZIP $0.039 116.67% 45,780,434
iBuyNew Group Ltd IBN $0.004 33.33% 250,000
Centaurus Metals Ltd CTM $0.004 33.33% 6,902,119
Dark Horse Resources Ltd DHR $0.004 33.33% 700,000
Subber Corporation Ltd DUB $0.345 32.69% 340,270
Holista Colltech Ltd HCT $0.130 31.31% 70,010
Admiralty Resources Ltd ADY $0.009 28.57% 518,696
Magnetite Mines Ltd MGT $0.028 27.27% 300,000

 

View full . profile View Profile

Proactive Investors Australia Timeline

Related Articles

mobile phone
June 19 2018
The marketing group has already said profits for the full-year will be ahead of expectations despite only being halfway through its current financial year
Lego
Wed
From an almost standing start in 2016, the group is scheduled to run Bricklive banded shows at 60 venues this year
Cello
April 16 2018
Global pharmaceutical R&D is forecast to reach $182bn by 2022 having grown at near 4% annually since 2006

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use